Atlas Trials

Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma

Clinical trial NCT03526679 · COMPLETED

Trial details

NCT number
NCT03526679
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
LeiomyosarcomaLiposarcomaSoft Tissue Sarcoma AdultAdvanced Cancer
Start date
2018-07-12
Primary completion
2021-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.